420305 Sigma-AldrichK-252c - CAS 85753-43-1 - Calbiochem
A cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (IC₅₀ = 2.45 µM) and protein kinase A (IC₅₀ = 25.7 µM).
More>> A cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (IC₅₀ = 2.45 µM) and protein kinase A (IC₅₀ = 25.7 µM). Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 85753-43-1 | C₂₀H₁₃N₃O |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 420305-1MG |
|
Plastic ampoule | 1 mg |
|
— |
| References | |
|---|---|
| References | Fabre, S., et al. 1993. Bioorg. Med. Chem. 1, 193. Nakanishi, S., et al. 1986. J. Antibiot. 39, 1066. |
| Product Information | |
|---|---|
| CAS number | 85753-43-1 |
| ATP Competitive | Y |
| Form | Off-white solid |
| Hill Formula | C₂₀H₁₃N₃O |
| Chemical formula | C₂₀H₁₃N₃O |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | PKC |
| Primary Target IC<sub>50</sub> | 2.45 µM against protein kinase C |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 420305-1MG | 04055977210927 |
Documentation
K-252c - CAS 85753-43-1 - Calbiochem SDS
| Title |
|---|
K-252c - CAS 85753-43-1 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 420305 |
References
| Reference overview |
|---|
| Fabre, S., et al. 1993. Bioorg. Med. Chem. 1, 193. Nakanishi, S., et al. 1986. J. Antibiot. 39, 1066. |



